Case Report

Case Report of Mastocytosis in an Adult

Authors: Allison Barker MD, Rosalyn W. Stewart MD, MS

Abstract

Abstract:A case of adult-onset mastocytosis is presented to illustrate the classification, signs, symptoms, workup, treatment, and prognosis for this unusual condition. Although there is no cure for mastocytosis, symptoms of histamine release can be minimized with oral antihistamines. Ongoing surveillance of organ systems affected remains important. Our patient’s mast cell disease predisposed him to bone loss, but there was no evidence of disease beyond the skin. He has done well with continued follow up monitoring his serum tryptase and oral antihistamine treatment.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

References1. Sézary A, Levy-Coblentz G, Chauvillon P. Dermographisme et mastocytose. Bull Soc Fr Dermatol Syphiligr 1936;43:359–361.SézaryA]]Levy-CoblentzG]]ChauvillonPDermographisme et mastocytose.Bull Soc Fr Dermatol Syphiligr193643359-3612. Valent P, Akin C, Sperr WR, et al. Mast cell proliferative disorders: current view on variants recognized by the World Health Organization. Hematol Oncol Clin North Am 2003;17:1227–1241.ValentP]]AkinC]]SperrWR&etal;Mast cell proliferative disorders: current view on variants recognized by the World Health Organization.Hematol Oncol Clin North Am2003171227-12413. Valent P, Akin C, Escribano L, et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007;37:435–453.ValentP]]AkinC]]EscribanoL&etal;Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.Eur J Clin Invest200737435-4534. Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001;25:603–625.ValentP]]HornyHP]]EscribanoL&etal;Diagnostic criteria and classification of mastocytosis: a consensus proposal.Leuk Res200125603-6255. Hartmann K, Henz BM. Mastocytosis: recent advances in defining the disease. Br J Dermatol 2001;144:682–695.HartmannK]]HenzBMMastocytosis: recent advances in defining the disease.Br J Dermatol2001144682-6956. Akoglu G, Erkin G, Cakir B, et al. Cutaneous mastocytosis: demographic aspects and clinical features of 55 patients. J Eur Acad Dermatol Venereol 2006;20:969–973.AkogluG]]ErkinG]]CakirB&etal;Cutaneous mastocytosis: demographic aspects and clinical features of 55 patients.J Eur Acad Dermatol Venereol200620969-9737. Janssens AS, Heide R, den Hollander JC. Mast cell distribution in normal adult skin. J Clin Pathol 2005;58:285–289.JanssensAS]]HeideR]]den HollanderJCMast cell distribution in normal adult skin.J Clin Pathol200558285-2898. Schwartz LB, Sakai K, Bradford TR, et al. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995;96:2702–2710.SchwartzLB]]SakaiK]]BradfordTR&etal;The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.J Clin Invest1995962702-27109. Almahroos M, Kurban AK. Management of mastocytosis. Clin Dermatol 2003;21:274–277.AlmahroosM]]KurbanAKManagement of mastocytosis.Clin Dermatol200321274-27710. Resh B, Jones E, Glaser DA. The cosmetic treatment of urticaria pigmentosa with Nd:YAG laser at 532 nanometers. J Cosmet Dermatol 2005;4:78–82.ReshB]]JonesE]]GlaserDAThe cosmetic treatment of urticaria pigmentosa with Nd:YAG laser at 532 nanometers.J Cosmet Dermatol2005478-8211. Kiszewski AE, Alvarez-Mendoza A, Rios-Barrera VA, et al. Mastocytosis in children: clinicopathological study based on 35 cases. Histol Histopathol 2007;22:535–539.KiszewskiAE]]Alvarez-MendozaA]]Rios-BarreraVA&etal;Mastocytosis in children: clinicopathological study based on 35 cases.Histol Histopathol200722535-539